Why China's vaccines are gaining international momentum


BEIJING (CGTN): There has been much news of late concerning Covid-19 vaccine progress from the two big American pharmacy firms, Pzifer and Moderna. It is hardly a surprise that the mainstream media behave as if these are the only two vaccine options available in the world and give them preferential coverage.

However, equal to the progress these companies have made, a number of Chinese firms are also pacing forward with third stage clinical trials of a coronavirus vaccine.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

China , vaccine , covid-19 , covax , Tom Fowdy , CGTN

   

Next In Aseanplus News

First Singaporean golfer at US Masters hopes 'not be in awe' of heroes
Four dead as helicopter crashes into hospital in Turkey
Disgraced top China banker Liu Liange married son’s girlfriend, causing his chronic depression
India child marriage crackdown reaches nearly 5,000 arrests
Cambodia to grant Japan visitation rights to China-linked naval base
Asean News Headlines at 10pm on Sunday (Dec 22, 2024)
Scientists struggle to explain record surge in global heat
OK for Muslims to wish Christians 'Merry Christmas', says Jakim
Asean will want inclusive Myanmar election, says bloc members
Tourists must register, book slots in Jan 2025 for NUS campus tours and pair up with student guide

Others Also Read